# US 2019/0315733 A1 · Heterocyclic inhibitors of glutaminase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0315733 A1
- Document ID: US20190315733A1
- Status: Published application
- Kind: A1
- Application number: 16/403,142
- Filed: 2019-05-03
- Published: 2019-10-17
- Earliest claimed: 2011-11-21
- Assignees: Calithera Biosciences, Inc.
- Applicants: Calithera Biosciences, Inc.
- Inventors: Jim Li; Lijing Chen; Bindu Goyal; Guy Laidig; Timothy F. Stanton; Eric B. Sjogren
- Web page: https://patentgrep.com/patent/US20190315733A1

## CPC

- C07D 417/14: containing three or more hetero rings
- A61B 18/02: by cooling, e.g. cryogenic techniques
- A61K 31/433: Thidiazoles
- A61K 31/501: not condensed and containing further heterocyclic rings
- A61K 31/506: not condensed and containing further heterocyclic rings
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61N 5/00: Radiation therapy (ultrasound therapy A61N7/00; devices or apparatus applicable to both therapy and diagnosis A61B6/00)
- A61N 5/10: X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy (A61N5/01 takes precedence)
- A61N 7/00: Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092})
- C07D 285/125: with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D 285/135: Nitrogen atoms
- C07D 417/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.

## Claims

### Claim at position 1

1-71. (canceled)

### Claim 72

A method of making a compound having the structure of formula A:
comprising combining a compound having the structure of formula B:
with a compound having the structure of formula C:
in dimethylformamide to form a mixture and treating the mixture with propylphosphonic anhydride and triethylamine, thereby forming a compound of formula A.

### Claim 73 (depends on 72)

The method of claim 72, further comprising combining a compound having the structure of formula D:
with a compound having the structure of formula E:
in the presence of trifluoroacetic acid, thereby forming a compound of formula B.

### Claim 74 (depends on 73)

The method of claim 73, further comprising combining a compound having the structure of formula F:
with BrZn(CH2)4CN solution and a NiCl2(dppp) catalyst, thereby forming a compound of formula D.

### Claim 75 (depends on 74)

The method of claim 74, further comprising combining a compound having the structure of formula G:
with a compound having the structure of formula H:
in the presence of dimethylformamide to form a mixture, then treating the mixture with diisopropylethylamine and propylphosphonic anhydride solution in dimethylformamide, thereby forming a compound of formula F.
